Patient Pathfinder: Clinical Trials
Clinical Trials for Multiple Sclerosis
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 295 active Multiple Sclerosis trials
Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple Sclerosis
Study Type: Interventional Phase 2
A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis
Study Type: Interventional Phase 1
An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer
Study Type: Interventional
A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Multiple Sclerosis and Their Infants
Study Type: Observational
A Study to Evaluate Safety and Efficacy of BIIB091 in Participants With Relapsing Forms of Multiple Sclerosis
Study Type: Interventional Phase 2
Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals
Study Type: Interventional Phase 1
Epidural Stimulation in Multiple Sclerosis
Study Type: Interventional
Effect of Cooling on Balance Performance in Multiple Sclerosis
Study Type: Observational
There are 295 active Multiple Sclerosis trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now